Source comparison
AOD-9604 Peptide vs Full-Length hGH: What the Structural Difference Changes
Amino Acid Sequence 176–191 C-terminal fragment + N-terminal tyrosine modification Complete 191-amino-acid polypeptide chain AOD-9604 lacks receptor domains for anabolic and glucose-regulatory effects Receptor Binding Beta-3 adrenergic receptors only GH recept
This comparison does not assign a generated winner or score.
- Amino Acid Sequence
- 176–191 C-terminal fragment + N-terminal tyrosine modification
- Complete 191-amino-acid polypeptide chain
- AOD-9604 lacks receptor domains for anabolic and glucose-regulatory effects
- Receptor Binding
- Beta-3 adrenergic receptors only
- GH receptors + beta-adrenergic receptors
- AOD-9604 isolates lipolytic pathway; hGH activates multiple systems
- Lipolytic Activity
- 12.5× baseline in isolated adipocytes
- 10–15× baseline, but confounded by insulin antagonism
- AOD-9604 provides 'clean' lipolysis without glucose interference
- Effect on Blood Glucose
- No measurable impact on fasting glucose or insulin sensitivity
- Dose-dependent insulin resistance and hyperglycemia
- AOD-9604 suitable for metabolic studies requiring stable glucose
- IGF-1 Production
- No IGF-1 upregulation
- Significant IGF-1 elevation (anabolic marker)
- AOD-9604 eliminates growth-promoting confounds
- Half-Life
- 8–12 hours (subcutaneous)
- 3–4 hours (requires daily dosing)
- AOD-9604 allows twice-daily dosing with stable plasma levels
- Storage Stability (Reconstituted)
- 28 days at 2–8°C
- 14–21 days at 2–8°C (formulation-dependent)
- AOD-9604 offers longer post-reconstitution viability
- Professional Assessment
- Preferred for fat metabolism research where glucose and IGF-1 must remain constant. Eliminates systemic hGH effects that confound lipid studies. Structural modification is the key differentiator. Not just 'less hGH,' but a fundamentally different receptor interaction profile.
- Necessary when studying growth, anabolic signaling, or IGF-1 pathways. Less useful for isolated lipolysis research due to multi-system activation.